Stock listing
Lang & Schwarz:A1C9RN Ligand Pharmaceuticals Incorporated Aktie
German listing (Lang & Schwarz) of Ligand Pharmaceuticals Incorporated · home listing NASDAQ:LGND
Follow Ligand Pharmaceuticals Incorporated into a list and get an email when it puts out news.
Home listing price · NASDAQ:LGND
$297.28 USD +1.74 (+0.6%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LGND
- Day range
- $295.74 – $303.86 USDOct 19, 2026
- Volume
- 116,989 sharesOct 19, 2026
- Market value
- $5.93B USDAt the close on Oct 19, 2026 · price × 19.94M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LGND · Home | $297.28 USD | +1.74 (+0.6%) | 116,989 | $300.41 | $303.86 | $295.74 | $295.54 | Close on Oct 19, 2026 |
| Frankfurt:LGDN | €262.00 EUR | +6.00 (+2.3%) | — | €260.00 | €262.00 | €260.00 | €256.00 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:LGND · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $297.28 | +1.74 | +0.6% | $300.41 | $303.86 | $295.74 | 116,989 | |
| $295.54 | -2.96 | -1.0% | $297.67 | $297.67 | $292.64 | 164,503 | |
| $298.50 | +3.51 | +1.2% | $297.82 | $304.60 | $296.97 | 332,106 | |
| $294.99 | -8.54 | -2.8% | $299.55 | $307.11 | $292.28 | 245,300 | |
| $303.53 | -7.60 | -2.4% | $311.72 | $311.72 | $300.23 | 196,558 | |
| $311.13 | +9.32 | +3.1% | $302.50 | $311.86 | $300.00 | 173,200 | |
| $301.81 | +6.81 | +2.3% | $294.79 | $304.78 | $294.32 | 183,000 | |
| $295.00 | +1.74 | +0.6% | $290.41 | $296.48 | $281.74 | 318,900 | |
| $293.26 | -3.68 | -1.2% | $293.63 | $301.27 | $292.47 | 309,200 | |
| $296.94 | -9.83 | -3.2% | $309.41 | $309.41 | $293.73 | 163,700 | |
| $306.77 | +3.81 | +1.3% | $303.95 | $309.77 | $300.79 | 163,800 | |
| $302.96 | +0.22 | +0.1% | $307.55 | $307.63 | $301.32 | 179,200 | |
| $302.74 | -9.63 | -3.1% | $309.82 | $312.05 | $301.48 | 374,000 | |
| $312.37 | +2.01 | +0.6% | $310.52 | $317.23 | $306.95 | 505,900 | |
| $310.36 | -3.74 | -1.2% | $313.63 | $317.10 | $304.36 | 431,000 | |
| $314.10 | +12.58 | +4.2% | $299.78 | $314.94 | $299.70 | 239,600 | |
| $301.52 | +2.48 | +0.8% | $303.17 | $305.35 | $293.90 | 305,800 | |
| $299.04 | +0.63 | +0.2% | $296.95 | $303.41 | $296.37 | 209,400 | |
| $298.41 | -0.09 | 0.0% | $300.44 | $302.44 | $296.08 | 242,000 | |
| $298.50 | +8.43 | +2.9% | $291.00 | $300.48 | $289.00 | 308,700 | |
| $290.07 | +6.58 | +2.3% | $283.67 | $290.51 | $282.45 | 237,400 | |
| $283.49 | -1.21 | -0.4% | $285.63 | $285.64 | $280.49 | 372,800 | |
| $284.70 | +9.50 | +3.5% | $279.51 | $285.51 | $273.10 | 248,800 | |
| $275.20 | -1.78 | -0.6% | $277.97 | $278.74 | $271.22 | 299,000 | |
| $276.98 | -3.67 | -1.3% | $280.53 | $280.53 | $270.77 | 180,200 | |
| $280.65 | -3.82 | -1.3% | $284.93 | $287.14 | $280.12 | 158,800 | |
| $284.47 | -4.78 | -1.7% | $291.48 | $294.00 | $283.77 | 261,200 | |
| $289.25 | +1.20 | +0.4% | $285.00 | $291.26 | $283.04 | 146,600 | |
| $288.05 | -0.78 | -0.3% | $288.03 | $291.82 | $285.48 | 310,000 | |
| $288.83 | +3.23 | +1.1% | $285.05 | $289.28 | $278.40 | 216,400 | |
| $285.60 | -4.14 | -1.4% | $287.41 | $290.00 | $285.47 | 132,400 | |
| $289.74 | +2.82 | +1.0% | $286.92 | $290.09 | $281.88 | 190,300 | |
| $286.92 | +2.65 | +0.9% | $285.73 | $290.33 | $281.69 | 189,600 | |
| $284.27 | +0.17 | +0.1% | $286.28 | $290.41 | $281.99 | 185,000 | |
| $284.10 | +3.61 | +1.3% | $276.77 | $285.90 | $275.60 | 203,700 | |
| $280.49 | -4.03 | -1.4% | $283.70 | $284.00 | $277.36 | 127,700 | |
| $284.52 | -3.33 | -1.2% | $284.71 | $289.20 | $282.40 | 206,300 | |
| $287.85 | +6.13 | +2.2% | $281.72 | $289.66 | $277.01 | 147,500 | |
| $281.72 | +1.54 | +0.5% | $284.22 | $287.90 | $278.28 | 197,400 | |
| $280.18 | -6.11 | -2.1% | $286.27 | $286.27 | $279.87 | 158,200 | |
| $286.29 | -1.10 | -0.4% | $288.09 | $289.98 | $285.21 | 152,500 | |
| $287.39 | -3.32 | -1.1% | $289.11 | $293.37 | $284.87 | 138,900 | |
| $290.71 | +3.12 | +1.1% | $291.02 | $294.61 | $282.25 | 231,200 | |
| $287.59 | -4.18 | -1.4% | $291.00 | $293.51 | $284.41 | 247,500 | |
| $291.77 | -2.83 | -1.0% | $292.47 | $298.29 | $291.73 | 145,600 | |
| $294.60 | +5.78 | +2.0% | $287.61 | $295.19 | $287.20 | 197,200 | |
| $288.82 | -4.45 | -1.5% | $294.99 | $294.99 | $285.24 | 255,400 | |
| $293.27 | +4.52 | +1.6% | $290.38 | $294.75 | $287.81 | 380,000 | |
| $288.75 | -6.95 | -2.4% | $295.01 | $299.34 | $288.60 | 368,500 | |
| $295.70 | +2.55 | +0.9% | $295.51 | $299.39 | $288.46 | 192,200 | |
| $293.15 | -6.99 | -2.3% | $304.37 | $304.60 | $286.65 | 313,600 | |
| $300.14 | -2.43 | -0.8% | $306.08 | $317.49 | $297.31 | 393,800 | |
| $302.57 | +1.78 | +0.6% | $305.26 | $308.56 | $300.07 | 197,100 | |
| $300.79 | +8.75 | +3.0% | $299.42 | $301.67 | $293.76 | 329,200 | |
| $292.04 | +4.50 | +1.6% | $287.00 | $293.23 | $283.77 | 191,700 | |
| $287.54 | -8.75 | -3.0% | $294.84 | $301.93 | $286.22 | 272,200 | |
| $296.29 | +8.28 | +2.9% | $287.78 | $303.00 | $286.45 | 283,300 | |
| $288.01 | -8.27 | -2.8% | $294.63 | $298.29 | $287.19 | 356,700 | |
| $296.28 | -1.22 | -0.4% | $301.28 | $301.29 | $293.53 | 353,500 | |
| $297.50 | -3.03 | -1.0% | $301.05 | $304.97 | $293.02 | 378,400 | |
| $300.53 | -1.62 | -0.5% | $302.72 | $307.81 | $297.18 | 277,000 | |
| $302.15 | -2.11 | -0.7% | $300.47 | $307.48 | $300.00 | 355,500 | |
| $304.26 | -1.21 | -0.4% | $308.18 | $308.56 | $302.20 | 205,500 | |
| $305.47 | +11.48 | +3.9% | $296.97 | $305.47 | $295.35 | 162,800 | |
| $293.99 | -9.40 | -3.1% | $304.06 | $308.56 | $293.69 | 395,600 |
- Ticker
- Lang & Schwarz:A1C9RN
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
Latest earnings call · Aug 6, 2026
Ligand Pharmaceuticals (NASDAQ:LGND) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 20 slides
Calls
Upcoming
Ligand Pharmaceuticals (NASDAQ:LGND) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:30 AM ET
Register
Replays
Ligand Pharmaceuticals (NASDAQ:LGND) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:30 AM ET
Watch TranscriptLigand Pharmaceuticals (NASDAQ:LGND) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptLigand Pharmaceuticals (NASDAQ:LGND) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
Oct 15, 2026
Closed $298.50 (+1.2%) on Oct 15, 2026
Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million
Sep 22, 2026
Closed $298.50 (+2.9%) on Sep 22, 2026
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 23, 2026
Closed $302.15 (-0.7%) on Jul 23, 2026
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Jul 14, 2026
Closed $300.97 (-2.7%) on Jul 14, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 20 slides · Aug 6, 2026
Investor Presentation (August 2026)
Investor deck · 23 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 20 slides · May 7, 2026
Merger or Acquisition (April 2026)
Merger or acquisition · 24 slides · Apr 27, 2026
Ligand Pharmaceuticals Incorporated on 6ix
- News releases
- 21 in the last 12 months · 180 in all · newest Oct 15, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 45 decks · latest Aug 6, 2026
Where Ligand Pharmaceuticals Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LGND · Home listing | NASDAQ | United States | USD |
| gettex:LGDN | gettex | Germany | EUR |
| Tradegate:LGDN | Tradegate | Germany | EUR |
| Lang & Schwarz:A1C9RN · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1C9RN | LS Exchange | Germany | EUR |
| BOATS:LGND | BOATS | United States | USD |
| Frankfurt:LGDN | Frankfurt | Germany | EUR |
| Stuttgart:LGDN | Stuttgart | Germany | EUR |
| BX Swiss:LGDN | BX Swiss | Switzerland | CHF |
| Dusseldorf:LGDN | Dusseldorf | Germany | EUR |
| Munich:LGDN | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Ligand Pharmaceuticals Incorporated.